Beta-Endorphin in Peripheral Blood Mononuclear Cells: Effect of Aging and Pharmacological Treatments

  • Paola Sacerdote
  • Emilio Clementi
  • Barbara Manfredi
  • Alberto E. Panerai
Part of the Hans Selye Symposia on Neuroendocrinology and Stress book series (HSSN, volume 3)


Beta-endorphin is known to affect the immune system when added in vitro or when its release is increased in vivo, e.g. during stress. Moreover, the synthesis of the beta-endorphin precursor proopiomelanocortin (POMC) has been consistently shown, by now, in several cells of the immune system, while the effect of extracellular beta-endorphin has been widely studied in vitro and in vivo. We investigated the synthesis of the opioid peptide in immune cells and its release from peripheral blood mononuclear cells obtained from normal subjects of different ages, both under resting conditions and after stimulation with polyclonal mitogens such as PHA or Con-A. The in vivo and in vitro modulation of intracellular beta-endorphin by pharmacological treatments is also described. Our findings indicate that the concentrations of beta-endorphin in peripheral blood mononuclear cells increase after the age of thirty years, and that the peptide is released by PHA or Con-A stimulation from cells obtained from subjects aged over thirty years, but not from cells of younger donors. Finally, we show that beta-endorphin is under a tonic inhibition exerted by the dopaminergic system, while serotonin exerts a tonic stimulatory effect. Preliminary data indicate that calcium homeostasis might be important for the differences observed in cells obtained from young (<30 years) or old (> 30 years) patients.


Peripheral Blood Mononuclear Cell Newcastle Disease Virus Sodium Valproate Peripheral Mononuclear Cell Peripheral Blood Mononuclear Cell Sample 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J.E. Morley, N.E. Kay, G.E. Solomon, and N.P. Plotnikoff, Neuropeptides: conductors of the immune orchestra, Life Sci. 41:527 (1987).PubMedCrossRefGoogle Scholar
  2. 2.
    P.M. Matthews, C.J. Froelich, W.L. Sibbitt, and A.D. Bankhurst, Enhancement of natural cytotoxicity by B-endorphin, J. Immunol 130:3045 (1983).Google Scholar
  3. 3.
    J.E. Blalock, A molecular basis for bidirectional communication between the immune and neuroendocrine system, Physiol. Rev. 69:1 (1989).PubMedGoogle Scholar
  4. 4.
    P. Sacerdote, F. Rubboli, L. Locatelli, I. Ciciliato, P. Mantegazza, and A.E. Panerai, Pharmacological modulation of neuropeptides in peripheral mononuclear cells, J. Neuroimmunol. 32:35 (1991).PubMedCrossRefGoogle Scholar
  5. 5.
    J.W. Rowe and R.L. Kahn, Human aging: usual and successful, Science 237:143 (1987).PubMedCrossRefGoogle Scholar
  6. 6.
    M.W. Weskler and G.W. Siskind, The cellular basis of immune senescence, Monogr. Dev. Biol. 17:110 (1984).Google Scholar
  7. 7.
    E.M. Smith and J.E. Blalock, Human lymphocyte production of ACTH and endorphin-like substances: Association with leucocyte itnerferon, Natl. Acad. Sci. USA 78:7530 (1981).CrossRefGoogle Scholar
  8. 8.
    D. Harbour-McMenamin, E.M. Smith and J.E. Blalock, Production of lymphocyte derived chorionic gonadotropin in a mixed lymphocyte reaction. Proc. Natl. Acad. Sci. USA 83:2599 (1986).CrossRefGoogle Scholar
  9. 9.
    R. Buzzetti, L. McLoughlin, P.M. Lavender, A.J. Clark and L.H. Rees, Expression of proopiomelanocortin gene and quantitization of adrenocorticotropic hormone like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies, J. Clin. Invest. 83:733 (1989).PubMedCrossRefGoogle Scholar
  10. 10.
    A.J.L. Clark, P.M. Lavender, P. Costes, M.E. Johnson and L.H. Rees, In vitro and in vivo analysis of the processing and fate of the peptide products of the short proopiomelanocortin mRNA, Mol. EndocrinolA’.mi (1990).Google Scholar
  11. 11.
    C.J. Heijnen, A. Kavelaars and R.E. Ballieux, b-endorphin: cytokine and neuropeptide, Immunol. Rev. 119:41 (1991).PubMedCrossRefGoogle Scholar
  12. 12.
    A. Rubartelli, F. Cozzolino, M. Talio and R.A. Sitia, A novel secretory pathway for interleukin-b, a protein lacking a signal sequence, EMBO J. 9:1503 (1990).PubMedGoogle Scholar
  13. 13.
    P.C.W. Lord, L.M.G. Wilmoth, S.B. Mizel and C.E. McCail, Expression of interleukin-1a and b genes by human blood polymorphonuclear leukocytes, J. Clin. Invest. 87:1312 (1991).PubMedCrossRefGoogle Scholar
  14. 14.
    G. Panza, E. Monzani, P. Sacerdote, G. Penati and A.E. Panerai, Beta-endorphin, vasoactive intestinal peptide and cholecystokinin in peripheral blood mononuclear cells from healthy subjects and from drug-free and haloperidol-treaed schizophrenic patients, Acta Psychiat. Scand. 85:207 (1982).CrossRefGoogle Scholar
  15. 15.
    M. Leone, P. Sacerdote, D. D’Amico, A.E. Panerai and G. Bussone, Beta-endorphin concentrations in the peripheral blood mononuclear cells of migraine and tension-type headache patients, Cephalagia 12:155 (1982).CrossRefGoogle Scholar
  16. 16.
    C.J. Wiedermann, P. Sacerdote, E. Mur, U. Kinigadner, T. Wicker, A.E. Panerai and H. Braunsteiner, Decreased immunoreactive beta-endorphin in mononuclear leukocytes from patients with rheumatic diseases, Clin. Exp. Immunol. 87:178 (1992).PubMedCrossRefGoogle Scholar
  17. 17.
    W. Barcellini, M.O. Borghi, C. Sguotti, R. Palmieri, D. Frasca, P.L. Meroni and C. Zanussi, Heterogeneity of immune responsiveness in healthy elderly subjects, Clin. Immunol. Immunopathol 47:142 (1988).PubMedCrossRefGoogle Scholar
  18. 18.
    G. Goldstein and T.K. Audhya, Thymopoietin to thymopeptin: experimental studies, Survey Immun. Res. 4, Suppl. 1:1 (1985).Google Scholar
  19. 19.
    S.R. Bareggi, M. Franceschi, L. Bonini, L. Zecca and S. Smirne, Decreased CSF concentrations of homovanillic acid and s-aminobutyric acid in Alzheimer’s disease, Arch. Neurol. 39:709 (1982).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Paola Sacerdote
    • 1
  • Emilio Clementi
    • 2
    • 3
  • Barbara Manfredi
    • 1
  • Alberto E. Panerai
    • 1
  1. 1.Department of PharmacologyUniversity of MilanoItaly
  2. 2.C.N.R. Centre of CytopharmacologyMilanoItaly
  3. 3.Department of Pharmacology, School of PharmaciUniversity of Reggio CalabriaCatanzaroItaly

Personalised recommendations